GABARAPL1 is required for increased EGFR membrane expression during hypoxia

Radiotherapy and Oncology

Volumn 116, Issue 3, 2015, Pages 417-422

  Keulers, Tom G ^a   Schaaf, Marco B E ^a   Peeters, Hanneke J M ^a   Savelkouls, Kim G M ^a   Vooijs, Marc A ^a   Bussink, Johan ^b   Jutten, Barry ^a   Rouschop, Kasper M A ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autophagy; EGFR; GABARAPL1; Hypoxia; Receptor trafficking; UPR

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ACTIVATING TRANSCRIPTION FACTOR 4; EPIDERMAL GROWTH FACTOR RECEPTOR; GABA A RECEPTOR ASSOCIATED PROTEIN LIKE 1; GLUCOSE TRANSPORTER 1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; MEMBRANE PROTEIN; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG; ANTIMETABOLITE; DOXYCYCLINE; EGFR PROTEIN, HUMAN; GABARAPL1 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANOXIA; CELL MEMBRANE; CELLULAR DISTRIBUTION; CHEMORADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HYPOXIA; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECURRENCE FREE SURVIVAL; THERAPY RESISTANCE; UPREGULATION; CELL HYPOXIA; CELL MOTION; GENE SILENCING; HEAD AND NECK TUMOR; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SQUAMOUS CELL CARCINOMA; TUMOR CELL CULTURE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANOXIA; ANTIMETABOLITES; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL MEMBRANE; CELL MOVEMENT; DOXYCYCLINE; GENE KNOCKDOWN TECHNIQUES; HEAD AND NECK NEOPLASMS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84944167107     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2015.06.023     Document Type: Conference Paper

References (34)

1. E. Lartigau, and et al. Variations in tumour oxygen tension (pO2) during accelerated radiotherapy of head and neck carcinoma Eur J Cancer 34 1998 856 861
2. M. Nordsmark, and et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiol Oncol 77 2005 18 24
3. S. Pennacchietti, and et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene Cancer Cell 3 2003 347 361
4. Q. Chang, and et al. Hypoxia predicts aggressive growth and spontaneous metastasis formation from orthotopically grown primary xenografts of human pancreatic cancer Cancer Res 71 2011 3110 3120
5. S.E. Rademakers, and et al. Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial Radiother Oncol 108 2013 517 522
6. K. Hirota, and G.L. Semenza Regulation of angiogenesis by hypoxia-inducible factor 1 Crit Rev Oncol Hematol 59 2006 15 26
7. E. Svastova, and et al. Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH FEBS Lett 577 2004 439 445
8. M. Koritzinsky, and et al. Two phases of disulfide bond formation have differing requirements for oxygen J Cell Biol 203 2013 615 627
9. P.D. Lu, H.P. Harding, and D. Ron Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response J Cell Biol 167 2004 27 33
10. E. Kojima, and et al. The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress: elucidation by GADD34-deficient mice Faseb J 17 2003 1573 1575
11. M. Koritzinsky, and et al. Phosphorylation of eIF2alpha is required for mRNA translation inhibition and survival during moderate hypoxia Radiother Oncol 83 2007 353 361
12. P. Walter, and D. Ron The unfolded protein response: from stress pathway to homeostatic regulation Science 334 2011 1081 1086
13. K.M. Rouschop, and et al. PERK/eIF2alpha signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS Proc Natl Acad Sci USA 110 2013 4622 4627
14. M.B. Schaaf, and et al. The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia Radiother Oncol 108 2013 529 534
15. K.M. Rouschop, and et al. The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 J Clin Invest 120 2010 127 141
16. J. Theys, and et al. The deletion mutant EGFRvIII significantly contributes to stress resistance typical for the tumour microenvironment Radiother Oncol 92 2009 399 404
17. A. Franovic, and et al. Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer Proc Natl Acad Sci USA 104 2007 13092 13097
18. M.M. Nijkamp, and et al. Interaction of EGFR with the tumour microenvironment: implications for radiation treatment Radiother Oncol 108 2013 17 23
19. C. Chen, and et al. Effects of C-terminal modifications of GEC1 protein and gamma-aminobutyric acid type A (GABA(A)) receptor-associated protein (GABARAP), two microtubule-associated proteins, on kappa opioid receptor expression J Biol Chem 286 2011 15106 15115
20. C. Chen, and et al. GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor J Biol Chem 281 2006 7983 7993
21. H. Wang, and R.W. Olsen Binding of the GABA(A) receptor-associated protein (GABARAP) to microtubules and microfilaments suggests involvement of the cytoskeleton in GABARAPGABA(A) receptor interaction J Neurochem 75 2000 644 655
22. J. Pramana, and et al. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer Int J Radiat Oncol Biol Phys 69 2007 1544 1552
23. M.H. Starmans, and et al. The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer Radiother Oncol 102 2012 436 443
24. H. Stegeman, and et al. Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models Radiother Oncol 106 2013 383 389
25. B.A. Hoeben, and et al. Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors BMC Cancer 14 2014 130
26. D.M. Brizel, and et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome Radiother Oncol 53 1999 113 117
27. M. Nordsmark, and et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
28. J. Alam, and et al. C-terminal processing of GABARAP is not required for trafficking of the angiotensin II type 1A receptor Regul Pept 159 2010 78 86
29. J.L. Cook, and et al. The trafficking protein GABARAP binds to and enhances plasma membrane expression and function of the angiotensin II type 1 receptor Circ Res 102 2008 1539 1547
30. Z.W. Chen, and et al. C-terminal modification is required for GABARAP-mediated GABA(A) receptor trafficking J Neurosci 27 2007 6655 6663
31. S.A. Weppler, and et al. Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance Radiother Oncol 83 2007 333 339
32. L. Chen, and et al. The gamma-aminobutyric acid type A (GABAA) receptor-associated protein (GABARAP) promotes GABAA receptor clustering and modulates the channel kinetics Proc Natl Acad Sci USA 97 2000 11557 11562
33. V. Mansuy, and et al. GEC1, a protein related to GABARAP, interacts with tubulin and GABA(A) receptor Biochem Biophys Res Commun 325 2004 639 648
34. Y. Chen, and et al. GEC1-kappa opioid receptor binding involves hydrophobic interactions: GEC1 has chaperone-like effect J Biol Chem 284 2009 1673 1685